Russell Investments Group, Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Russell Investments Group, Ltd.
- $84.2 Billion
- Q3 2025
A detailed history of Russell Investments Group, Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 251,378 shares of XERS stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
251,378
Previous 123,189
104.06%
Holding current value
$1.82 Million
Previous $575,000
254.09%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...